Join
Live feed
·
INSIDERFilingvia Quantisnow
Pyxis Oncology Inc. logo

SEC Form 4: Sullivan Lara sold $18,161 worth of shares (8,641 units at $2.10), decreasing direct ownership by 0.36% to 2,403,882 units

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PYXS (Pyxis Oncology Inc.) and more on Quantisnow.